JP2000229901A - New method for production of phenoxyalkylhalide derivative - Google Patents

New method for production of phenoxyalkylhalide derivative

Info

Publication number
JP2000229901A
JP2000229901A JP11033497A JP3349799A JP2000229901A JP 2000229901 A JP2000229901 A JP 2000229901A JP 11033497 A JP11033497 A JP 11033497A JP 3349799 A JP3349799 A JP 3349799A JP 2000229901 A JP2000229901 A JP 2000229901A
Authority
JP
Japan
Prior art keywords
general formula
following general
halide
represented
alkoxyphenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11033497A
Other languages
Japanese (ja)
Other versions
JP3662761B2 (en
Inventor
Yoshinori Kato
義則 加藤
Hideki Kato
秀樹 加藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP03349799A priority Critical patent/JP3662761B2/en
Publication of JP2000229901A publication Critical patent/JP2000229901A/en
Application granted granted Critical
Publication of JP3662761B2 publication Critical patent/JP3662761B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a derivative of phenoxyalkylhalide in high purity and yield useful as a synthetic intermediate for tamsulosin hydrochloride by reacting a halogenide to a specific (alkoxyphenoxy)ethyl compound. SOLUTION: The (C) derivative of phenoxyalkylhalide of formula II (X is a halogen) is obtained by reacting (B) the halogenide to the (alkoxyphenoxy) ethyl compound expressed by formula I (R is a lower alkyl; and Y is a leaving group). The substituted sulfamoyl phenethylamines (e.g. tamsulosin hydrochloride) (E) of formula IV can be obtained by reacting amine compound (D) of formula III (R1 and R3 are each H or a lower alkyl; R2 is OH, a lower alkyl or the like; and R6 is H or a halogen) to the obtained component (C) [e.g. (o- ethoxyphenoxy)ethyl bromide]. The component (E) is a compound having adrenoreceptor blocking action.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する分野】本発明は、(R)−5−[2−
[[2−(o−エトキシフェノキシ)エチル]アミノ]
−2−メチルエチル]−2−メトキシベンゼンスルフォ
ンアミド塩酸塩(一般名“タムスロシン・塩酸塩”)を
含む一連のスルファモイル置換フェネチルアミン誘導体
の工業上優れた製造中間体として有用なフェノキシアル
キルハライド誘導体、特に、2−(o−エトキシフェノ
キシ)エチルハライドの新規製造法に関するものであ
り、また、該中間体を経由する前記スルファモイル置換
フェネチルアミン誘導体の新規製造法に関するものであ
る。
The present invention relates to (R) -5- [2-
[[2- (o-ethoxyphenoxy) ethyl] amino]
Phenoxyalkyl halide derivatives, particularly useful as an industrially superior intermediate for the production of a series of sulfamoyl-substituted phenethylamine derivatives, including -2-methylethyl] -2-methoxybenzenesulfonamide hydrochloride (general name "tamsulosin hydrochloride"), , 2- (o-ethoxyphenoxy) ethyl halide and a novel process for producing the sulfamoyl-substituted phenethylamine derivative via the intermediate.

【0002】[0002]

【従来の技術】従来、一般的なフェノキシアルキルハラ
イドの製造法としては、フェノールとアルキレンジハラ
イドとを用いて縮合させる方法が知られている。即ち、
J.Med.Chem.8(3)356−367(19
65)には、o―メトキシフェノールとエチレンジハラ
イドとを水酸化ナトリウムの存在下に反応させることが
記載されている。しかしながら、フェノキシアルキルハ
ライドを製造する為に、アルカリ存在下に低級アルコキ
シフェノールとアルキレンジハライドとを反応させる方
法は本発明者等が追試してみたところ、アルキレンジハ
ライドと2つのアルコキシフェノールが縮合した2量体
である1,2−ビス(アルコキシフェノキシ)エタンが
大量に副成してしまい、目的物の生成率を低下させると
共に、その後の蒸留精製が不可欠なものであった。ま
た、上記文献の実験例に従ってエチレン1,2−ジブロ
マイドをo−エトキシフェノールに対して2等量使用し
た場合には、目的物の2−(o−エトキシフェノキシ)
エチルブロマイドの他2量体である1,2−ビス(o−
エトキシフェノキシ)エタンが副成した。この2量体の
副成を抑制する為には、アルコキシフェノールに対して
大過剰のアルキレンジハライド使用が必要となるが、ア
ルキレンジハライドがアルカリにより分解して副成され
るビニルハライドがより低沸点で飛散し易い物質である
為、環境保全或いは安全衛生面における問題点を有して
いた。また、大量に副成した2量体を除去するために不
可欠な高温、高真空での蒸留精製は、工業生産上は特殊
設備を要する為に、規模拡大や操作性及び経済効果にお
いて大きなマイナス要因とされていた。
2. Description of the Related Art Heretofore, as a general method for producing a phenoxyalkyl halide, a method of condensing phenol and an alkylenedihalide has been known. That is,
J. Med. Chem. 8 (3) 356-367 (19
65) describes reacting o-methoxyphenol with ethylene dihalide in the presence of sodium hydroxide. However, in order to produce a phenoxyalkyl halide, a method of reacting a lower alkoxyphenol and an alkylene dihalide in the presence of an alkali was additionally tested by the present inventors, and the alkylene dihalide was condensed with two alkoxyphenols. A large amount of 1,2-bis (alkoxyphenoxy) ethane, which is a dimer, is formed as a by-product, which lowers the production rate of the target product, and further requires subsequent purification by distillation. Further, when ethylene 1,2-dibromide is used in an amount of 2 equivalents to o-ethoxyphenol according to the experimental examples in the above-mentioned literature, the desired product 2- (o-ethoxyphenoxy) is used.
The other dimer of ethyl bromide, 1,2-bis (o-
Ethoxyphenoxy) ethane was by-produced. In order to suppress the by-product formation of the dimer, it is necessary to use a large excess of alkylene dihalide with respect to the alkoxyphenol. However, the amount of vinyl halide formed by decomposition of the alkylene dihalide by alkali is lower. Since it is a substance that is easily scattered at the boiling point, it has a problem in terms of environmental protection or health and safety. In addition, distillation and purification at high temperature and high vacuum, which are indispensable for removing a large amount of by-product dimers, require special equipment in industrial production, and therefore have a large negative effect on scale expansion, operability, and economic effects. And it was.

【0003】一方、本発明の目的化合物であるフェノキ
シアルキルハライドは、ベンジルアミンなどのアミノ化
合物と反応させてそのアミン誘導体を製造するための重
要な中間体として有用な化合物である。例えば、特公昭
62−52742号には対応するアミン誘導体を反応さ
せることにより、優れたα−アドレナリン受容体遮断作
用を有し血圧降下剤として有用なスルファモイル置換フ
ェネチルアミン誘導体が得られることが記載されてい
る。これらのα−アドレナリン受容体遮断作用を有する
化合物のうち、タムスロシン・塩酸塩は本出願人会社に
よって開発され、前立腺肥大に伴う排尿障害の治療剤と
して既に販売されており、本発明の目的化合物であるフ
ェノキシアルキルハライド誘導体並びにタムスロシン・
塩酸塩自体を安価且つ収率よく製造するための製造法の
開発が望まれていた。
On the other hand, a phenoxyalkyl halide, which is an object compound of the present invention, is a compound useful as an important intermediate for producing an amine derivative by reacting with an amino compound such as benzylamine. For example, Japanese Patent Publication No. 62-52742 discloses that a sulfamoyl-substituted phenethylamine derivative having an excellent α-adrenergic receptor blocking action and useful as a hypotensive agent can be obtained by reacting a corresponding amine derivative. I have. Among these compounds having an α-adrenergic receptor blocking action, tamsulosin hydrochloride has been developed by the present applicant company, and has already been marketed as a therapeutic agent for dysuria associated with prostatic hypertrophy. Certain phenoxyalkyl halide derivatives and tamsulosin
It has been desired to develop a production method for producing the hydrochloride itself at low cost and with good yield.

【0004】[0004]

【発明が解決しようとする課題】本発明は、一般式
(I)で示されるフェノキシアルキルハライド誘導体の
新規製法を提供することを課題とする。また、本発明の
目的化合物である一般式(I)を使用する特にタムスロ
シン・塩酸塩の新規製法を提供することを課題とする。
An object of the present invention is to provide a novel process for producing a phenoxyalkyl halide derivative represented by the general formula (I). Another object of the present invention is to provide a novel process for producing tamsulosin hydrochloride, particularly using the general formula (I), which is the target compound of the present invention.

【0005】[0005]

【課題を解決するための手段】本発明者等はフェノキシ
アルキルハライド誘導体の新規製法並びに一般式(I)
を使用する特にはタムスロシン・塩酸塩の新規製法に関
し鋭意研究した結果本発明を完成した。
Means for Solving the Problems The present inventors have prepared a novel process for producing a phenoxyalkyl halide derivative and a compound represented by the general formula (I):
The present invention has been completed as a result of intensive studies on a novel method for producing tamsulosin hydrochloride using phenol.

【0006】[0006]

【課題を解決するための手段】即ち、本発明は下記製造
法に関する。 1)下記一般式(II)で示される(アルコキシフェノキ
シ)エチルスルフォニル化合物に
That is, the present invention relates to the following production method. 1) An (alkoxyphenoxy) ethylsulfonyl compound represented by the following general formula (II)

【化14】 (式中、Rは低級アルキル基を、Yは脱離基を意味す
る。以下同様) ハロゲン化物を反応させることを特徴とする下記一般式
(I)で示されるフェノキシアルキルハライド誘導体の製
造法。(以下、製法1という。)
Embedded image (Wherein, R represents a lower alkyl group and Y represents a leaving group. The same applies hereinafter.) The following general formula characterized by reacting a halide:
A method for producing the phenoxyalkyl halide derivative represented by (I). (Hereinafter, referred to as production method 1.)

【化15】 (式中、Xはハロゲン原子を意味する。) 2)下記一般式(III)で示される(アルコキシフェノキ
シ)エチルアルコールに、
Embedded image (Wherein X represents a halogen atom.) 2) (Alkoxyphenoxy) ethyl alcohol represented by the following general formula (III):

【化16】 スルフォニルハロゲン化物を反応させ下記一般式(II)で
示される(アルコキシフェノキシ)エチルスルフォニル
化合物とした後、
Embedded image After reacting a sulfonyl halide to give an (alkoxyphenoxy) ethylsulfonyl compound represented by the following general formula (II),

【化17】 ハロゲン化物を反応させることを特徴とする下記一般式
(I)で示されるフェノキシアルキルハライド誘導体の製
造法。(以下、製法2という。)
Embedded image The following general formula characterized by reacting a halide
A method for producing the phenoxyalkyl halide derivative represented by (I). (Hereinafter, it is referred to as manufacturing method 2.)

【化18】 3)下記一般式(IV)で示される低級アルコキシフェノー
ルと
Embedded image 3) a lower alkoxyphenol represented by the following general formula (IV)

【化19】 炭酸エチレン又は酸化エチレンを反応させ下記一般式(I
II)で示される(アルコキシフェノキシ)エチルアルコ
ールとし、
Embedded image Reaction of ethylene carbonate or ethylene oxide with the following general formula (I
(Alkoxyphenoxy) ethyl alcohol represented by II),

【化20】 更に、アルキルスルフォニルハロゲン化物を反応させ下
記一般式(II)で示される(アルコキシフェノキシ)エチ
ルスルフォニル化合物とした後、
Embedded image Further, after reacting an alkylsulfonyl halide to give an (alkoxyphenoxy) ethylsulfonyl compound represented by the following general formula (II),

【化21】 ハロゲン化物を反応させることを特徴とする下記一般式
(I)で示されるフェノキシアルキルハライド誘導体の製
造法。(以下、製法3という。)
Embedded image The following general formula characterized by reacting a halide
A method for producing the phenoxyalkyl halide derivative represented by (I). (Hereinafter referred to as Production Method 3.)

【化22】 4) 下記一般式(II)で示される(アルコキシフェノキ
シ)エチルスルフォニル化合物に
Embedded image 4) An (alkoxyphenoxy) ethylsulfonyl compound represented by the following general formula (II)

【化23】 ハロゲン化アルカリ金属を反応させる下記一般式(I)で
示されるフェノキシアルキルハライドとし、
Embedded image A phenoxyalkyl halide represented by the following general formula (I) for reacting an alkali metal halide,

【化24】 下記一般式で示されるアミン化合物(V)Embedded image Amine compound (V) represented by the following general formula

【化25】 (式中、R1、R3は水素原子又は低級アルキル基を、R
2は水酸基、低級アルキル基、又は−O−低級アルキル
基を、R6は水素原子又はハロゲン原子を意味する。以
下同様)を反応させることを特徴とする下記一般式で示
されるスルファモイル置換フェネチルアミン誘導体の製
造法(以下、製法4という。)
Embedded image (Wherein R 1 and R 3 represent a hydrogen atom or a lower alkyl group;
2 represents a hydroxyl group, a lower alkyl group, or —O-lower alkyl group, and R 6 represents a hydrogen atom or a halogen atom. The same applies hereinafter) to produce a sulfamoyl-substituted phenethylamine derivative represented by the following general formula (hereinafter referred to as Production Method 4).

【化26】 Embedded image

【0007】[0007]

【発明の実施の形態】本発明の一般式の基の定義におい
て、低級アルキル基とは炭素数1〜5個の直鎖状又は分
枝状のアルキル基を意味する。この例としては、メチ
ル、エチル、プロピル、イソプロピル、ブチル、ペンチ
ル、イソペンチル等であり、好ましくは、メチル、エチ
ル、プロピル等である。また、ハロゲン原子としてはフ
ッ素、塩素、臭素等である。以下に本発明製法を詳述す
る。尚、製法1及び製法2は製法3の各工程に含まれる
ため(製法1は製法3の第3工程、製法2は製法3の第
2及び第3工程)、下記製法の説明では、製法3及び製
法4について詳述する。
BEST MODE FOR CARRYING OUT THE INVENTION In the definition of the group represented by the general formula of the present invention, a lower alkyl group means a linear or branched alkyl group having 1 to 5 carbon atoms. Examples are methyl, ethyl, propyl, isopropyl, butyl, pentyl, isopentyl and the like, preferably methyl, ethyl, propyl and the like. The halogen atom includes fluorine, chlorine, bromine and the like. Hereinafter, the production method of the present invention will be described in detail. In addition, since the manufacturing method 1 and the manufacturing method 2 are included in each step of the manufacturing method 3 (the manufacturing method 1 is the third step of the manufacturing method 3, and the manufacturing method 2 is the second and third steps of the manufacturing method 3), the manufacturing method 3 will be described in the following description of the manufacturing method. And Production Method 4 will be described in detail.

【0008】1)製法31) Manufacturing method 3

【化27】 本製法の第1工程は一般式(IV)で示される低級アル
コキシフェノールに塩基存在下又は不存在下、等量乃至
過剰量の炭酸エチレン又は酸化エチレンを室温乃至加熱
下反応させ一般式(III)で示される(アルコキシフ
ェノキシ)エチルアルコールを得る工程である。
Embedded image In the first step of the present production method, an equivalent to excess amount of ethylene carbonate or ethylene oxide is reacted with a lower alkoxyphenol represented by the general formula (IV) in the presence or absence of a base at room temperature or under heating to obtain a compound of the general formula (III) Is a step of obtaining (alkoxyphenoxy) ethyl alcohol represented by

【0009】この反応を円滑に進行させるため塩基を添
加しても良い。この場合の塩基としては、有機或いは無
機の塩基で有れば、特に限定されないが、好ましくは、
無機塩基であり、例えば、炭酸カリウム、炭酸ナトリウ
ム、炭酸水素ナトリウム等の炭酸塩、水酸化ナトリウ
ム、水酸化カリウムなどの水酸化物、水素化ナトリウ
ム、水素化リチウム等の水素化金属、臭化テトラブチル
アンモニウムなどの4級アンモニウム塩等である。
A base may be added to make the reaction proceed smoothly. The base in this case is not particularly limited as long as it is an organic or inorganic base, but preferably,
Inorganic bases, for example, carbonates such as potassium carbonate, sodium carbonate and sodium hydrogen carbonate, hydroxides such as sodium hydroxide and potassium hydroxide, metal hydrides such as sodium hydride and lithium hydride, tetrabromide And quaternary ammonium salts such as butyl ammonium.

【0010】また、反応溶媒としては、反応に関与しな
い溶媒であれば限定されないが、好ましくは反応を促進
させるため高温化で行う為、高沸点の溶媒、例えば、ジ
メチルホルムアミド、ジメチルアセタミド、ジメチルス
ルフォキシド或いはこれらの混合溶媒等が挙げられる。
また、この反応は必要により溶媒不存在下にも行うこと
ができる。反応時間は、数時間乃至24時間程度であ
る。
The reaction solvent is not limited as long as it does not participate in the reaction. Preferably, the reaction is carried out at a high temperature in order to promote the reaction, so that a solvent having a high boiling point, for example, dimethylformamide, dimethylacetamide, Dimethyl sulfoxide or a mixed solvent thereof is exemplified.
This reaction can be carried out in the absence of a solvent, if necessary. The reaction time is about several hours to 24 hours.

【0011】このようにして得られた(アルコキシフェ
ノキシ)エチルアルコールは単離され或いは単離せずし
てそのまま次工程に付される。
The (alkoxyphenoxy) ethyl alcohol obtained in this way is isolated or not isolated, and is directly subjected to the next step.

【0012】本製法の第2工程は一般式(III)で示
される(アルコキシフェノキシ)エチルアルコールに塩
基存在下又は不存在下、等量乃至過剰量のスルフォニル
ハロゲン化物を冷却下乃至室温下反応させ一般式(I
I)で示される(アルコキシフェノキシ)エチルスルフ
ォニル化合物を得る工程である。
In the second step of the present process, an equivalent to excess amount of a sulfonyl halide is reacted with (alkoxyphenoxy) ethyl alcohol represented by the general formula (III) in the presence or absence of a base under cooling to room temperature. The general formula (I
This is a step of obtaining the (alkoxyphenoxy) ethylsulfonyl compound represented by I).

【0013】スルフォニルハロゲン化物としては、塩化
メタンスルフォニル、塩化エタンスルフォニル、塩化ベ
ンゼンスルフォニル、塩化トルエンスルフォニル或いは
これらのスルフォン酸無水物等のスルフォニル化剤であ
り、従って、一般式(II)で示される化合物中、Yの
意味する脱離基としては、メチルスルフォニルオキシ
基、トルエンスルフォニルオキシ基等である。この反応
を円滑に進行させるため塩基を添加しても良い。この場
合の塩基としては、有機或いは無機の塩基で有れば、特
に限定されないが、好ましくは、有機塩基であり、例え
ばトリエチルアミン、トリメチルアミン、ピリジン、ピ
コリン、ルチジン等である。反応溶媒としては、反応に
関与しない溶媒、例えば、ジメチルホルムアミド、ジメ
チルアミド、ジオキサン、テトラヒドロフラン、ジクロ
ロエタン、クロロホルム、四塩化炭素、ジメトキシメタ
ン、ジメトキシエタン、酢酸エチル、ベンゼン、トルエ
ン、アセトニトリル、ジメチルスルホキシド等やこれら
の混合溶媒が挙げられる。反応時間は、数分乃至24時
間程度である。このようにして得られた(アルコキシフ
ェノキシ)エチルスルフォニル化合物は単離され或いは
単離せずしてそのまま次工程に付すことができる。
The sulfonyl halide is a sulfonylating agent such as methanesulfonyl chloride, ethanesulfonyl chloride, benzenesulfonyl chloride, toluenesulfonyl chloride or sulfonic anhydride thereof. Therefore, the compound represented by the general formula (II) In the formula, the leaving group represented by Y includes a methylsulfonyloxy group, a toluenesulfonyloxy group and the like. A base may be added to make this reaction proceed smoothly. The base in this case is not particularly limited as long as it is an organic or inorganic base, but is preferably an organic base, for example, triethylamine, trimethylamine, pyridine, picoline, lutidine and the like. As the reaction solvent, a solvent that does not participate in the reaction, for example, dimethylformamide, dimethylamide, dioxane, tetrahydrofuran, dichloroethane, chloroform, carbon tetrachloride, dimethoxymethane, dimethoxyethane, ethyl acetate, benzene, toluene, acetonitrile, dimethyl sulfoxide and the like These mixed solvents are mentioned. The reaction time is about several minutes to 24 hours. The (alkoxyphenoxy) ethylsulfonyl compound thus obtained can be isolated or can be directly subjected to the next step without isolation.

【0014】本製法の第3工程は一般式(II)で示さ
れる(アルコキシフェノキシ)エチルスルフォニル化合
物に等量乃至過剰量のハロゲン化物を室温下乃至加熱下
反応させ本発明の目的化合物である一般式(I)で示さ
れるフェノキシアルキルハライドを得る工程である。
In the third step of the present process, an (alkoxyphenoxy) ethylsulfonyl compound represented by the general formula (II) is reacted with an equivalent amount or an excess amount of a halide at room temperature or under heating to obtain the desired compound of the present invention. This is a step of obtaining a phenoxyalkyl halide represented by the formula (I).

【0015】ハロゲン化物としては、例えば、臭化リチ
ウム、臭化カリウム、臭化マグネシウム、臭化カルシウ
ム、臭化テトラブチルアンモニウム等である。反応溶媒
としては、反応に不活性な溶媒で有れば特に制限はな
く、例えば、アセトン、メチルエチルケトン、酢酸エチ
ル、ベンゼン、トルエン、テトラヒドロフラン、ジクロ
ロエタン、クロロホルム、四塩化炭素、アセトニトリ
ル、ジメチルスルホキシド等である。反応時間は、1時
間乃至24時間程度であり、反応温度は、室温下乃至加
熱下である。このようにして得られた目的化合物(I)
は、周知の方法、例えば、抽出、沈殿、クロマトグラフ
ィー、分別結晶化、再結晶等により単離精製することが
できる。工業的には再結晶による精製が好ましい。
Examples of the halide include lithium bromide, potassium bromide, magnesium bromide, calcium bromide, tetrabutylammonium bromide and the like. The reaction solvent is not particularly limited as long as it is a solvent inert to the reaction, and examples thereof include acetone, methyl ethyl ketone, ethyl acetate, benzene, toluene, tetrahydrofuran, dichloroethane, chloroform, carbon tetrachloride, acetonitrile, and dimethyl sulfoxide. . The reaction time is about 1 hour to 24 hours, and the reaction temperature is from room temperature to heating. The target compound (I) thus obtained
Can be isolated and purified by well-known methods, for example, extraction, precipitation, chromatography, fractional crystallization, recrystallization and the like. Industrially, purification by recrystallization is preferred.

【0016】2)製法42) Production method 4

【化28】 Embedded image

【0017】本製法は、一般式(II)で示される(ア
ルコキシフェノキシ)エチルスルフォニル化合物を本発
明の目的化合物(I)とした後、一般式(V)で示され
るアミン化合物と反応させ、一般式(VI)で示される
スルファモイル置換フェネチルアミン誘導体を製造する
方法である。
In this production method, an (alkoxyphenoxy) ethylsulfonyl compound represented by the general formula (II) is converted into the target compound (I) of the present invention, and then reacted with an amine compound represented by the general formula (V). This is a method for producing a sulfamoyl-substituted phenethylamine derivative represented by the formula (VI).

【0018】即ち、上記製法3第3工程により得られた
本発明化合物(I)に対して等量乃至過剰量の一般式
(V)で示されるアミン化合物を室温下乃至加温下、或
いは加熱還流して反応させることにより行うことができ
る。反応溶媒としては、ベンゼン、トルエン、キシレ
ン、ジメチルホルムアミド、ジクロロメタン、ジクロロ
エタン、メタノール、エタノール等の反応に関与しない
溶媒で有れば特に制限はない。また反応に際し、ピリジ
ン、ピコリン、N、N−ジメチルアニリン、N−メチル
モルホリン、トリエチルアミン、ジメチルアニリン等の
有機塩基、炭酸カリウム、炭酸水素ナトリウム、炭酸ナ
トリウム等を添加すると反応を円滑に進行させる上で有
利な場合がある。この製法の具体的態様については後記
実施例並びに特公昭62−52742号参照のこと。
That is, an equimolar amount or an excess amount of the amine compound represented by the general formula (V) with respect to the compound of the present invention (I) obtained in the third step of the above-mentioned Production Method 3 is added at room temperature to under heating or by heating. The reaction can be carried out by refluxing. The reaction solvent is not particularly limited as long as it is a solvent that does not participate in the reaction, such as benzene, toluene, xylene, dimethylformamide, dichloromethane, dichloroethane, methanol, and ethanol. In addition, upon the reaction, addition of an organic base such as pyridine, picoline, N, N-dimethylaniline, N-methylmorpholine, triethylamine, dimethylaniline, potassium carbonate, sodium hydrogen carbonate, sodium carbonate, etc., in order to make the reaction proceed smoothly May be advantageous. For the specific embodiment of this production method, see Examples described later and JP-B-62-52742.

【0019】[0019]

【実施例】以下に、本発明を更に具体的に開示するため
に、実施例を記載するが、本発明は実施例に限定される
ものではない。
EXAMPLES The present invention will be described below in more detail with reference to examples, but the present invention is not limited to the examples.

【0020】(実施例1)o−エトキシフェノール 5
0g(1.0等量)、炭酸エチレン 38.2g(1.2等
量)、炭酸カリウム 2.5g(0.05等量)をDMF
250mlに加え、約110℃で終夜攪拌して2−(o
−エトキシフェノキシ)エタノールを得る。 冷却後、
酢酸エチル 500mlとトリエチルアミン 54.9g
(1.5等量)を加えた後、0℃以下で塩化メタンスル
ホニル 58.0g(1.4等量)を滴下する。 滴下
後、水 1000mlとメチルエチルケトン 200ml
の混合液に分散して有機層を取り、更に10%臭化ナト
リウム水溶液 500mlで洗浄した後に得た有機層を
濃縮し2−(o−エトキシフェノキシ)エチルメタンス
ルフォネートを得る。 濃縮後、メチルエチルケトン
250mlと臭化リチウム・一水和物 75.9g(2.
0等量)を加えて、約90℃に3時間程度加温する。
冷却後に、水 500mlと酢酸エチル 150mlに分
散し、取り出した有機層を1%炭酸カリウム水溶液 3
00ml、次いで、水 300mlで順次洗浄し、得た
有機層を濃縮する。 濃縮残査を85%メタノール水溶
液 300mlで再結晶し、真空乾燥すると2−(o−
エトキシフェノキシ)エチルブロマイドを72.4g
(融点:44〜45℃、純度:99.1%)得た。
(Example 1) o-ethoxyphenol 5
0 g (1.0 equivalent), 38.2 g (1.2 equivalent) of ethylene carbonate, and 2.5 g (0.05 equivalent) of potassium carbonate in DMF
250 ml and stirred at about 110 ° C. overnight to give 2- (o
-Ethoxyphenoxy) ethanol is obtained. After cooling,
500 ml of ethyl acetate and 54.9 g of triethylamine
After adding (1.5 equivalents), 58.0 g (1.4 equivalents) of methanesulfonyl chloride are added dropwise at 0 ° C. or lower. After dripping, 1000 ml of water and 200 ml of methyl ethyl ketone
The organic layer was dispersed in the above mixture, and the organic layer was washed with 500 ml of a 10% aqueous sodium bromide solution. The obtained organic layer was concentrated to obtain 2- (o-ethoxyphenoxy) ethyl methanesulfonate. After concentration, methyl ethyl ketone
250 ml and lithium bromide monohydrate 75.9 g (2.
(0 equivalent), and warm to about 90 ° C. for about 3 hours.
After cooling, the mixture was dispersed in 500 ml of water and 150 ml of ethyl acetate.
It wash | cleans sequentially by 00 ml and then 300 ml of water, and concentrates the obtained organic layer. The concentrated residue was recrystallized from an 85% aqueous methanol solution (300 ml) and dried under vacuum to obtain 2- (o-
72.4 g of ethoxyphenoxy) ethyl bromide
(Melting point: 44-45 ° C., purity: 99.1%).

【0021】(実施例2)実施例1と同様にして得られ
る2−(o−エトキシフェノキシ)エチルメタンスルフ
ォネートにメチルエチルケトンと臭化リチウム・一水和
物 を加えて、約90℃に3時間程度加温する。 冷却
後に、水 と酢酸エチルに分散し、取り出した有機層を
1%炭酸カリウム水溶液、次いで、水 で順次洗浄し、
得た有機層を濃縮する。 濃縮残査を85%メタノール
水溶液で再結晶し、真空乾燥すると2−(o−エトキシ
フェノキシ)エチルブロマイドを得る。この化合物とR
(−)−5−[(2−アミノ−2−メチル)エチル]−
2−メトキシベンゼンスルフォンアミドをエタノールに
溶解し、加熱還流する。反応後溶媒を留去して残留物を
10%水酸化ナトリウム水でアルカリ性にし、析出油状
物を酢酸エチルで抽出し、抽出液を飽和塩化ナトリウム
水溶液で洗い、無水硫酸マグネシウムで乾燥する。溶液
を留去し、常法により精製し、塩酸エタノールで処理し
て(R)−5−[2−[[2−(o−エトキシフェノキ
シ)エチル]アミノ]−2−メチルエチル]−2−メト
キシベンゼンスルフォンアミド塩酸塩を得る。
Example 2 To 2- (o-ethoxyphenoxy) ethyl methanesulfonate obtained in the same manner as in Example 1, methyl ethyl ketone and lithium bromide monohydrate were added, and the mixture was heated to about 90 ° C. Heat for about an hour. After cooling, the mixture was dispersed in water and ethyl acetate, and the extracted organic layer was washed successively with a 1% aqueous potassium carbonate solution and then with water.
The obtained organic layer is concentrated. The concentrated residue is recrystallized from an 85% aqueous methanol solution and dried under vacuum to obtain 2- (o-ethoxyphenoxy) ethyl bromide. This compound and R
(-)-5-[(2-amino-2-methyl) ethyl]-
Dissolve 2-methoxybenzenesulfonamide in ethanol and heat to reflux. After the reaction, the solvent is distilled off, the residue is made alkaline with 10% aqueous sodium hydroxide, the precipitated oil is extracted with ethyl acetate, and the extract is washed with a saturated aqueous sodium chloride solution and dried over anhydrous magnesium sulfate. The solution is distilled off, purified by a conventional method, and treated with ethanol hydrochloride to give (R) -5- [2-[[2- (o-ethoxyphenoxy) ethyl] amino] -2-methylethyl] -2-. Obtain methoxybenzenesulfonamide hydrochloride.

【0022】[0022]

【発明の効果】本発明製法によれば、α−アドレナリン
受容体遮断作用を有する一連のスルファモイル置換フェ
ネチルアミン誘導体、殊に、タムスロシン・塩酸塩の製
造中間体として有用な目的化合物(I)を高純度且つ高
収率(一般式(IV)で示される化合物からの収率は8
0%以上に達する)で得ることができる。また、原料と
してアルキルジハロゲン化物を使用せず、汎用性の高い
原料を使用することができる。そして、そのアルカリ分
解物のハロゲン化ビニル(揮発性が高い)が副成しない
為、工業生産における環境保全及び安全確保上優れてい
る。更に、不純物として2量体が副成しない為、これを
除去する為に不可欠な高温、高真空での特殊蒸留設備を
必要とせず一般汎用設備で対応できる為に生産規模の拡
大が容易となって生産性やエネルギー効率が向上し経済
的に安価となる。また、目的化合物(I)が蒸留時の高
温下にさらされない為、分解等の二次的問題が生じない
点でも優れた製法である。従って、目的化合物(I)は
勿論、最終生成物であるタムスロシン・塩酸塩を工業的
に製造する場合の製法としては極めて優れた製法といえ
る。また、目的化合物(I)を経由して最終物質である
タムスロシン・塩酸塩を含む一連のスルファモイル置換
フェネチルアミン誘導体へ至る経路は上記製法4とな
る。
According to the process of the present invention, a high purity of the target compound (I) useful as an intermediate for producing a series of sulfamoyl-substituted phenethylamine derivatives having an α-adrenergic receptor blocking action, particularly tamsulosin hydrochloride, is obtained. And a high yield (the yield from the compound represented by the general formula (IV) is 8
0% or more). In addition, a highly versatile raw material can be used without using an alkyl dihalide as a raw material. Since the alkali decomposition product vinyl halide (having a high volatility) is not produced as a by-product, it is excellent in environmental conservation and safety assurance in industrial production. Further, since dimer is not formed as an impurity, the production scale can be easily expanded because general-purpose equipment can be used without special distillation equipment at high temperature and high vacuum which is indispensable for removing dimer. As a result, productivity and energy efficiency are improved, and the cost is reduced economically. Further, since the target compound (I) is not exposed to the high temperature during distillation, it is an excellent production method in that secondary problems such as decomposition do not occur. Therefore, it can be said that this is an extremely excellent production method for industrially producing tamsulosin hydrochloride as a final product as well as the target compound (I). The route to the series of sulfamoyl-substituted phenethylamine derivatives containing tamsulosin hydrochloride as the final substance via the target compound (I) is the above-mentioned production method 4.

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 下記一般式(II)で示される(アルコキ
シフェノキシ)エチル化合物に 【化1】 (式中、Rは低級アルキル基を、Yは脱離基を意味す
る。以下同様) ハロゲン化物を反応させることを特徴とする下記一般式
(I)で示されるフェノキシアルキルハライド誘導体の製
造法。 【化2】 (式中、Xはハロゲン原子を意味する。)
1. An (alkoxyphenoxy) ethyl compound represented by the following general formula (II): (Wherein, R represents a lower alkyl group and Y represents a leaving group. The same applies hereinafter.) The following general formula characterized by reacting a halide:
A method for producing the phenoxyalkyl halide derivative represented by (I). Embedded image (In the formula, X means a halogen atom.)
【請求項2】 下記一般式(III)で示される(アルコ
キシフェノキシ)エチルアルコールに、 【化3】 スルフォニルハロゲン化物を反応させ下記一般式(II)で
示される(アルコキシフェノキシ)エチルスルフォニル
化合物とした後、 【化4】 (式中、Yは脱離基を意味する。以下同様) ハロゲン化物を反応させることを特徴とする下記一般式
(I)で示されるフェノキシアルキルハライド誘導体の製
造法。 【化5】 (式中、Xはハロゲン原子を意味する。)
2. An (alkoxyphenoxy) ethyl alcohol represented by the following general formula (III): After reacting a sulfonyl halide to give an (alkoxyphenoxy) ethylsulfonyl compound represented by the following general formula (II), (Wherein, Y represents a leaving group; the same applies hereinafter) The following general formula wherein a halide is reacted:
A method for producing the phenoxyalkyl halide derivative represented by (I). Embedded image (In the formula, X means a halogen atom.)
【請求項3】 下記一般式(IV)で示される低級アルコ
キシフェノールと 【化6】 (式中、Rは低級アルキル基を意味する。以下同様) 炭酸エチレン又は酸化エチレンを反応させ下記一般式(I
II)で示される(アルコキシフェノキシ)エチルアルコ
ールとし、 【化7】 更に、アルキルスルフォニルハロゲン化物を反応させ下
記一般式(II)で示される(アルコキシフェノキシ)エチ
ルスルフォニル化合物とした後、 【化8】 (式中、Yは脱離基を意味する。以下同様) ハロゲン化物を反応させることを特徴とする下記一般式
(I)で示されるフェノキシアルキルハライド誘導体の製
造法。 【化9】 (式中、Xはハロゲン原子を意味する。)
3. A lower alkoxyphenol represented by the following general formula (IV): (Wherein, R represents a lower alkyl group; the same applies hereinafter) Ethylene carbonate or ethylene oxide is reacted and the following general formula (I
(Alkoxyphenoxy) ethyl alcohol represented by II), Further, an alkylsulfonyl halide is reacted to give an (alkoxyphenoxy) ethylsulfonyl compound represented by the following general formula (II). (Wherein, Y represents a leaving group; the same applies hereinafter) The following general formula wherein a halide is reacted:
A method for producing the phenoxyalkyl halide derivative represented by (I). Embedded image (In the formula, X means a halogen atom.)
【請求項4】 下記一般式(II)で示される(アルコ
キシフェノキシ)エチルスルフォニル化合物に 【化10】 (式中、Rは低級アルキル基を、Yは脱離基を意味す
る。以下同様) ハロゲン化物を反応させることにより下記一般式(I)で
示されるフェノキシアルキルハライドとし、 【化11】 (式中、Rは低級アルキル基を、Xはハロゲン原子を意
味する。以下同様) これに下記一般式で示されるアミン化合物(V) 【化12】 (式中、R1、R3は水素原子又は低級アルキル基を、R
2は水酸基、低級アルキル基、又は−O−低級アルキル
基を、R6は水素原子又はハロゲン原子を意味する。以
下同様)を反応させることを特徴とする下記一般式で示
されるスルファモイル置換フェネチルアミン誘導体の製
造法。 【化13】
4. An (alkoxyphenoxy) ethylsulfonyl compound represented by the following general formula (II): (Wherein, R represents a lower alkyl group, Y represents a leaving group, and the same applies hereinafter) By reacting a halide, a phenoxyalkyl halide represented by the following general formula (I) is obtained. (Wherein, R represents a lower alkyl group, X represents a halogen atom, and the same applies hereinafter). In addition, an amine compound (V) represented by the following general formula: (Wherein R 1 and R 3 represent a hydrogen atom or a lower alkyl group;
2 represents a hydroxyl group, a lower alkyl group, or —O-lower alkyl group, and R 6 represents a hydrogen atom or a halogen atom. The same applies hereinafter) to produce a sulfamoyl-substituted phenethylamine derivative represented by the following general formula. Embedded image
【請求項5】 一般式(I)で示される化合物が2−
(o−エトキシフェノキシ)エチルブロマイドである請
求項1〜4何れか1項記載の製造法
5. The compound represented by the general formula (I) is 2-
The method according to any one of claims 1 to 4, which is (o-ethoxyphenoxy) ethyl bromide.
JP03349799A 1999-02-10 1999-02-10 New production method of phenoxyalkyl halide derivatives Expired - Lifetime JP3662761B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03349799A JP3662761B2 (en) 1999-02-10 1999-02-10 New production method of phenoxyalkyl halide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03349799A JP3662761B2 (en) 1999-02-10 1999-02-10 New production method of phenoxyalkyl halide derivatives

Publications (2)

Publication Number Publication Date
JP2000229901A true JP2000229901A (en) 2000-08-22
JP3662761B2 JP3662761B2 (en) 2005-06-22

Family

ID=12388197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03349799A Expired - Lifetime JP3662761B2 (en) 1999-02-10 1999-02-10 New production method of phenoxyalkyl halide derivatives

Country Status (1)

Country Link
JP (1) JP3662761B2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002068382A1 (en) * 2001-02-23 2002-09-06 Yonsung Fine Chemical Co. Ltd. Process for preparing sulfamoyl-substituted phenethylamine derivatives
WO2005056521A1 (en) * 2003-12-09 2005-06-23 Cj Corporation Method of preparing optically pure phenethylamine derivatives
FR2864079A1 (en) * 2003-12-17 2005-06-24 Prod Chim Auxiliaires Et De Sy Preparation of 1-phenyl-2-substituted aminopropane derivatives, useful as intermediates for the muscle relaxant R-tamsulosine, by reacting unsubstituted amine with reactive phenoxyacetic acid derivative
JP2006232757A (en) * 2005-02-25 2006-09-07 Ohara Yakuhin Kogyo Kk Method for producing phenoxyethyl halide and its derivative
WO2006019358A3 (en) * 2004-08-16 2006-12-07 Scinopharm Singapore Pte Ltd Process for preparing tamsulosin
JP2007015975A (en) * 2005-07-07 2007-01-25 Well Being Biochemical Corp Production method for tamusulosin and relating allyl derivative
JP2007517797A (en) * 2003-12-29 2007-07-05 レツク・フアーマシユーテイカルズ・デー・デー Preparation of highly chemical R-5- (2- (2-ethoxyphenoxyethylamino) propyl) -2-methoxybenzenesulfonamide hydrochloride
CN1328249C (en) * 2006-02-22 2007-07-25 江阴市金山化工有限公司 Prepn process of (R)-(-)-5-(2-aminopropyl)-2-methoxyl benzene sulfonamide
WO2015159672A1 (en) * 2014-04-17 2015-10-22 株式会社ダイセル Method for producing halogen compound, method for producing potassium salt, and potassium salt
CN106478467A (en) * 2016-10-13 2017-03-08 深圳万和制药有限公司 The method for preparing stable tamsulosin hydrochloride
JP2018035185A (en) * 2017-10-13 2018-03-08 株式会社ダイセル Method for producing potassium salt, and potassium salt

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6914159B1 (en) 2001-02-23 2005-07-05 Yonsung Fine Chemical Co., Ltd. Process for preparing sulfamoyl-substituted phenethylamine derivatives
WO2002068382A1 (en) * 2001-02-23 2002-09-06 Yonsung Fine Chemical Co. Ltd. Process for preparing sulfamoyl-substituted phenethylamine derivatives
WO2005056521A1 (en) * 2003-12-09 2005-06-23 Cj Corporation Method of preparing optically pure phenethylamine derivatives
US7329780B2 (en) 2003-12-09 2008-02-12 Cj Corporation Method of preparing optically pure phenethylamine derivatives
FR2864079A1 (en) * 2003-12-17 2005-06-24 Prod Chim Auxiliaires Et De Sy Preparation of 1-phenyl-2-substituted aminopropane derivatives, useful as intermediates for the muscle relaxant R-tamsulosine, by reacting unsubstituted amine with reactive phenoxyacetic acid derivative
US7619116B2 (en) 2003-12-17 2009-11-17 Products Chimiques Auxiliaires Et de Synthese Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation
JP2007517797A (en) * 2003-12-29 2007-07-05 レツク・フアーマシユーテイカルズ・デー・デー Preparation of highly chemical R-5- (2- (2-ethoxyphenoxyethylamino) propyl) -2-methoxybenzenesulfonamide hydrochloride
US7332621B2 (en) 2004-08-16 2008-02-19 Scinopharm Taiwan Ktd. Process for preparing Tamsulosin
WO2006019358A3 (en) * 2004-08-16 2006-12-07 Scinopharm Singapore Pte Ltd Process for preparing tamsulosin
JP2006232757A (en) * 2005-02-25 2006-09-07 Ohara Yakuhin Kogyo Kk Method for producing phenoxyethyl halide and its derivative
JP4540060B2 (en) * 2005-07-07 2010-09-08 国際威林生化科技股▲ふん▼有限公司 Method for producing tamsulosin
JP2007015975A (en) * 2005-07-07 2007-01-25 Well Being Biochemical Corp Production method for tamusulosin and relating allyl derivative
CN1328249C (en) * 2006-02-22 2007-07-25 江阴市金山化工有限公司 Prepn process of (R)-(-)-5-(2-aminopropyl)-2-methoxyl benzene sulfonamide
WO2015159672A1 (en) * 2014-04-17 2015-10-22 株式会社ダイセル Method for producing halogen compound, method for producing potassium salt, and potassium salt
CN106232564A (en) * 2014-04-17 2016-12-14 株式会社大赛璐 The manufacture method of halogenide, the manufacture method of potassium salt and potassium salt
CN106478467A (en) * 2016-10-13 2017-03-08 深圳万和制药有限公司 The method for preparing stable tamsulosin hydrochloride
JP2018035185A (en) * 2017-10-13 2018-03-08 株式会社ダイセル Method for producing potassium salt, and potassium salt

Also Published As

Publication number Publication date
JP3662761B2 (en) 2005-06-22

Similar Documents

Publication Publication Date Title
EP1806340B1 (en) Indoline compound and process for producing the same
TW201002700A (en) Processes to make apoptosis promoters
US8981095B2 (en) Intermediate compounds and process for the preparation of lurasidone and salts thereof
CA2486533C (en) Preparations of a sulfinyl acetamide
TWI666203B (en) Process for manufacturing pyrimidine sulfamide derivatives
JP2000229901A (en) New method for production of phenoxyalkylhalide derivative
TWI343909B (en) Process for making galantamine
JPH09509929A (en) Epoxide synthesis method
JPWO2004022514A1 (en) Method for producing spirofluorenol
JPH04235976A (en) Production of aralkylaminopyrimidine compounds
JP2021523950A (en) Methods for stereoselective preparation of chiral 2-[(hetero) arylalkylsulfanyl] pyrimidines and products obtained from them
JPH04308538A (en) Halogenation
KR100596373B1 (en) Processes for preparing optically pure phenethylamine derivatives
JP4886948B2 (en) Biphenylethylamine derivative and method for producing the same
JP2002220371A (en) Method for producing n-vinyl carbazoles
KR102365411B1 (en) Novel sulfonamide intermediates and processes for preparing silodosin using the same
WO2007132990A1 (en) Process for the preparation of chiral glycidylphthalimide in highly optical purity
JPH0327353A (en) Preparation of sulfonium compound
JP2002356480A (en) Method for producing trans-(5r)-2,4,5-trisubstituted 2- oxazoline
JP4571505B2 (en) Process for producing 1- [2- (benzimidazol-2-ylthio) ethyl] piperazine or a salt thereof
JPH10195039A (en) Production of arylvinylsulfone
JP4236482B2 (en) Method for producing dicarboxylic acid derivative
JP2000309595A (en) Production of n-[5-(diphenylphosphinoylmethyl)-4-(4- fluorophenyl)-6-isopropylpyrimidin-2-yl-n- methylmethanesulphonamide
JPWO2004011451A1 (en) Industrial production of optically active 1,4-benzodioxane derivatives
NO326162B1 (en) Process for the preparation of 4- (imidazol-1-yl) benzenesulfonamide derivatives.

Legal Events

Date Code Title Description
A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20040903

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20041001

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20040914

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20041221

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050209

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20050322

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20050324

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090401

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090401

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100401

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110401

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120401

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130401

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130401

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130401

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140401

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140401

Year of fee payment: 9

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140401

Year of fee payment: 9

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term